San Jose, CA, United States of America

Aridis Pharmaceuticals

Calculating rank
USPTO Granted Patents = 9

% Expired Patents = 22.2


Forward Citations = 44

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Satoshi Ohtake (6 out of 6 patents)

silverMedal Vu Truong-Le (6 out of 18 patents)

bronzeMedal Luisa Yee (5 out of 6 patents)

4.  Binh Pham (4 out of 12 patents)

5.  Russell E Martin (4 out of 12 patents)

6.  David Lechuga-Ballesteros (3 out of 22 patents)

7.  Atul Saxena (3 out of 3 patents)

8.  Simon Urwyler (2 out of 19 patents)

9.  Michael Rudolf (2 out of 12 patents)

10.  Holger Koch (2 out of 3 patents)

11.  Markus Haake (1 out of 12 patents)

12.  Vu Truong (1 out of 2 patents)

13.  Michael Rodolf (1 out of 1 patent)

14.  Vu L Truong (3 patents)

15.  Laurent Bernard Jean Strodiot (2 patents)


9 patents:

Company Overview
Aridis Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of novel anti-infectives for life-threatening infectious diseases. Their proprietary technology platform leverages the human immune system to identify and develop antibodies that can effectively treat a wide range of infectious diseases. Aridis is committed to addressing unmet medical needs and improving patient outcomes through innovative drug development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#557 in San Jose, CA

#7,745 in California

#32,605 in US

San Jose, CA (US)
San Jose, CA, United States of America
Forward Citations = 44

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aridis Pharmaceuticals. Retrieved from https://idiyas.com/company/aridis-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…